LabGenius Therapeutics uses its EVA automated discovery platform, combining human and machine intelligence, to discover and co-optimise therapeutic antibodies
LabGenius Therapeutics uses its EVA automated discovery platform, combining human and machine intelligence, to discover and co-optimise therapeutic antibodies. Its internal pipeline focuses on selectivity-enhanced antibody treatments for solid tumours, including complex multispecific antibodies.